Version 5.4
Bos taurus Protein: L3MBTL3
Summary
InnateDB Protein IDBP-684822.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol L3MBTL3
Protein Name lethal(3)malignant brain tumor-like protein 3
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000056210
InnateDB Gene IDBG-633116 (L3MBTL3)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0006355 regulation of transcription, DNA-templated
GO:0030099 myeloid cell differentiation
GO:0030225 macrophage differentiation
GO:0030851 granulocyte differentiation
GO:0043249 erythrocyte maturation
Cellular Component
GO:0005634 nucleus
Protein Structure and Domains
PDB ID
InterPro IPR001660 Sterile alpha motif domain
IPR004092 Mbt repeat
IPR011510 Sterile alpha motif, type 2
IPR013761 Sterile alpha motif/pointed domain
IPR021129 Sterile alpha motif, type 1
PFAM PF02820
PF07647
PF00536
PRINTS
PIRSF
SMART SM00454
SM00561
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL G3N2U0
UniProt Splice Variant
Entrez Gene 524334
UniGene
RefSeq XP_005210974
HUGO HGNC:23035
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02026614 DAAA02026615 DAAA02026616 DAAA02026617
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca